#868: Tim’s Founder Kitchen — From Brainstorm to The President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics)

In this episode of The Tim Ferriss Show, host Tim Ferriss interviews Jake Becraft, CEO of Strand Therapeutics, a biotech company aiming to revolutionize cancer treatment through programmable genetic medicines. Becraft describes the limitations of current cancer therapeutics, which often focus on the liver, and how Strand’s innovations aim to deliver treatments more broadly throughout the body.

The discussion includes the importance of storytelling in conveying complex biotech ideas to policymakers and investors. Becraft emphasizes the need to shift the narrative from merely outlining problems to presenting potent solutions, drawing parallels with other industries such as aerospace and tech. The importance of regulatory reform in expediting clinical trials in the U.S. is underscored, as is the need for significant investments in biotech to foster innovation and address pressing health challenges.

Becraft also reflects on the potential future of personalized medicine, where delivery systems allow for tailored treatments based on individual patient needs. He highlights the role of AI in enhancing drug discovery and the critical shift needed in the investor landscape towards supporting long-term, high-risk biotech endeavors.